Indirect neurotoxin proof of chronic borreliosis by a visual contrast sensitivity test;Indirekter neurotoxinnachweis durch den »visual contrast sensitivity«-test bei patienten mit einer chronischen borreliose

Medizinische Welt

Volumn 54, Issue 9, 2003, Pages 248-251

  Hartmann, Fred ^a   Muller Marienburg H ^a  

^a NONE

Author keywords

Bbtox 1; Borrelia burgdorferi; Lyme borreliosis; VCS Test; Visual contrast sensitivity Test

Indexed keywords

BORRELIA BURGDORFERI TOXIN 1; NEUROTOXIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; BRAIN INJURY; CHILD; CLINICAL FEATURE; DIAGNOSTIC TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS TISSUE; NONHUMAN; SENSITIVITY AND SPECIFICITY; SPIROCHETE; TOXIN ANALYSIS; VISUAL CONTRAST SENSITIVITY TEST;

EID: 0141703243     PISSN: 00258512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Shoemaker RC. Desperation medicine, Gateway Press, Inc., Baltimore, MD 2001.
2. Shoemaker RC. Residential and recreational acquisition of possible estuary-associated syndrome: A new approach to successful diagnosis and treatment. Environmental Health Perspectives 2001; 109: Supp. 5.
3. Shoemaker RC, Hudnell HK. Possible estuary-associated syndrome: symptoms, vision, and treatment. Environmental Health Perspectives, 2001; 109.
4. Cartwright MJ, Martin SE, Donta ST. A novel neurotoxin (Bbtox 1) of Borrelia burgdorferi. Meeting of the American Society for Microbiology. May 1999, Chicago.
5. Ginsburg, AP. A new contrast sensitivity vision test chart. Am J Opt Physiol Opt 1984; 61: 403-7.
6. Ginsburg AP et al. Large sample norms for contrast sensitivity. Am J Opt Physiol Opt 1984; 61: 80-4.
7. Nadler MP, Miller D and Nadler DJ. Glare and contrast sensitivity for clinicians, NY: Springer-Verlag, 1990.
8. Shoemaker RC. Treatment of possible estuary-associated syndrome: neurotoxins, contrast sensitivity and colestyramine (Abstract). Presented at the CDC National Conference on Pfiesteria: from Biology to Public Health, 18-20 October 2000, Stone Mountain, GA.
9. Donta ST. Late and chronic Lyme disease: Symptom overlap with chronic fatigue syndrom and fibromyalgia (15. May 2002).
10. Donta ST. The existence of chronic Lyme disease. Current treatment options in infectious disease 2001; 3: 261-2.
11. Hudnell HK. Human visual function in the North Carolina study on Pfisteria piscicida. For the North Carolina Department of Health and Human Services and the North Carolina Task Force on Pfisteria. Dean William Roper, Chairmen, University of North Carolina School of Public Health (US EPA #600-R-98_1323), Cincinnati 1998.
12. Hudnell HK. Persönliche Mitteilung Okt. 2002.
13. Burkholder JM. Eine Giftalge mit vielen Tarnkappen. Spectrum d Wissensch 2000; 1: 66-73.
14. Carmichael WW. Health risk from exposure to Cyanobacteria harmful algae blooms. http//www.unibs.it/~lucchini/abstracts/MiniSymp3.htm.
15. Hudnell HK. Chronic Lyme disease may be caused by toxins. Lyme Times/www.lymedisease.org.
16. Burrascano JJ. Diagnostic hints and treatment guidelines for Lyme and other tick borne illnesses. http://www.ilads.org/burrascano-1102.htm.
17. Kronemeyer B. Visual contrast sensivity test helps screen for Ciguatera. Infectiouse Disease News 2001; March: 42.
18. Hassler D. Die Lyme Borreliopse verstehen und richtig handeln. Fortschr Med. 1989; 116: 45-6.
19. Bleiweiss JD. When to suspect Lyme! www.cassia.org/essay.htm.
20. Dattwyler RJ, Luft BJ. Antibiotic treatment of Lyme Borreliosis. Biomed. Parmacother. 1989; 43: 421-6.
21. Dattwyler RJ. Treatment of late Lyme Borreliosis. Lancet 1988; 1: 1191-4.
22. Phillips SE et al. Proposal for reliable culture of Borrelia burgdorferi from patients with chronic lyme disease, even from those previously agressively treated. Infection 1998; 26: 364-7.
23. Rasley A, Auguita J, Mariott J. Borrelia burgdorferi induces inflammtory mediator production by murine microglia. J Neuroimm 2002; 130: 22-33.
24. Nadelman RB, Wormser GP. Lyme Borreliosis. Lancet 1998; 352: 557-65.
25. Magnarelli LA et al. Coexistence of antibiotics to tick-borne pathogens of Babesiosis, Ehrlichiosis and Borreliosis in human sera. J Clin Microbiol 1995; 33,3054-7.
26. Engstrom, SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995; 33: 419-27.
27. Thompson Ch, Spielman A, Krause PJ. Coinfecting deer-associated zoonoses: Lyme disease, Babesiosis, Ehrlichiosis. Clin Pract CID 2001; 33: 666-83.
28. Contrast vision test developed by Arthur P. Ginsburg Ph.D. Licensed under U.S. Patent #4,365,837 and 5,414,479 by Copyright 1999.Stereo Opticac Co.